A Win for Trabectedin in High-Grade Myxoid Liposarcoma?

(MedPage Today) -- Neoadjuvant trabectedin (Yondelis) for high-grade myxoid liposarcoma (HG-MLPS) demonstrated noninferiority to the long-time standard of anthracycline-ifosfamide (AI), according to new data from a previously completed trial....
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news